The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests.
This is the third in a series of five posts outlining the leading infectious diseases or infectious disease groups in terms of IVD market sales. Previous posts were for HIV/AIDS and respiratory tract infection tests.
Tests for viral hepatitis infections, primarily hepatitis C virus (HCV) and hepatitis B virus (HBV), are among the most common infectious disease tests run in clinical laboratories. Untreated, hepatitis infections can cause tremendous health problems after years or decades of latency. Similar to human immunodeficiency virus (HIV) infections, chronic hepatitis infections are treated with antiviral drugs. The efficacy of antiviral treatment is monitored using quantitative viral load assays. Additional applications for hepatitis diagnostics include the characterization and typing of hepatitis infections to optimize clinical treatment and the screening of donated blood for transfusion medicine. Hepatitis diagnostics represents a vast and diverse market; total IVD revenue is estimated well above $2 billion with demand across geographies and test settings from high-complexity clinical labs through points of care.